Gene · 7402
Papers3,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest. | Nat Commun | 2022 | 36068222 | PubTator, text mining | PubMed |
| Structural mechanism for bidirectional actin cross-linking by T-plastin. | Proc Natl Acad Sci U S A | 2022 | 36067297 | PubTator, text mining | PubMed |
| Cathelicidin-related antimicrobial peptide mediates skeletal muscle degeneration caused by injury and Duchenne muscular dystrophy in mice. | J Cachexia Sarcopenia Muscle | 2022 | 36059045 | PubTator, text mining | PubMed |
| Mid51/Fis1 mitochondrial oligomerization complex drives lysosomal untethering and network dynamics. | J Cell Biol | 2022 | 36044022 | PubTator, text mining | PubMed |
| Tandem duplication within the DMD gene in Labrador retrievers with a mild clinical phenotype. | Neuromuscul Disord | 2022 | 36041985 | PubTator, text mining | PubMed |
| Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants. | PLoS One | 2022 | 36037157 | PubTator, text mining | PubMed |
| Alterations of Mitochondrial Structure in Methamphetamine Toxicity. | Int J Mol Sci | 2022 | 36012188 | PubTator, text mining | PubMed |
| Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development. | Biomedicines | 2022 | 36009412 | PubTator, text mining | PubMed |
| Markers of Oxidative Stress in Obstetrics and Gynaecology-A Systematic Literature Review. | Antioxidants (Basel) | 2022 | 36009196 | PubTator, text mining | PubMed |
| Merging of ventral fibers at adhesions drives the remodeling of cellular contractile systems in fibroblasts. | Cytoskeleton (Hoboken) | 2022 | 35996927 | PubTator, text mining | PubMed |
| The new challenge of "exercise + X″ therapy for Duchenne muscular dystrophy-Individualized identification of exercise tolerance and precise implementation of exercise intervention. | Front Physiol | 2022 | 35991169 | PubTator, text mining | PubMed |
| MTP18 inhibition triggers mitochondrial hyperfusion to induce apoptosis through ROS-mediated lysosomal membrane permeabilization-dependent pathway in oral cancer. | Free Radic Biol Med | 2022 | 35985563 | PubTator, text mining | PubMed |
| Activated TRPA1 plays a therapeutic role in TMZ resistance in glioblastoma by altering mitochondrial dynamics. | BMC Mol Cell Biol | 2022 | 35982414 | PubTator, text mining | PubMed |
| Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection. | Emerg Microbes Infect | 2022 | 35976035 | PubTator, text mining | PubMed |
| Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1. | J Biol Chem | 2022 | 35973513 | PubTator, text mining | PubMed |
| Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study. | Ther Clin Risk Manag | 2022 | 35971461 | PubTator, text mining | PubMed |
| Noncanonical PDK4 action alters mitochondrial dynamics to affect the cellular respiratory status. | Proc Natl Acad Sci U S A | 2022 | 35969774 | PubTator, text mining | PubMed |
| The influence of metabolic syndrome on age-related hearing loss from the perspective of mitochondrial dysfunction. | Front Aging Neurosci | 2022 | 35966796 | PubTator, text mining | PubMed |
| CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells. | Theranostics | 2022 | 35966591 | PubTator, text mining | PubMed |
| The role of Cdk5 in neurological disorders. | Front Cell Neurosci | 2022 | 35966199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/papers?page=56